Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Perugia
Clinical trial register · Italy

Clinical Trials in Perugia, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 137 Naples 79 Roma 71 Florence 57 Padova 56
Narrow the registerReset
Recruitment status
Phase
Site location
Milan137 Naples79 Roma71 Florence57 Padova56
All 111 locations
Target enrolment
to

Trials with a site in Perugia

10 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
AstraZeneca
Phase 3
6,950
Ancona, Bergamo, Brescia, Milan, Pavia, Perugia, Riccione, Salerno
2026-08-24
Recruiting
AstraZeneca
Phase 2
435
Milan, Palermo, Pavia, Perugia, Roma, Rozzano, Torrette
2025-11-06
Recruiting
AstraZeneca
Phase 3
1,220
Bologna, Milan, Palermo, Perugia, Pisa, Roma, Rozzano
2025-05-06
Recruiting
Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
NCT06651970Chronic Lymphocytic Leukaemia, Moderate to Severe Cardiac Impairment
AstraZeneca
Phase 4
60
Cagliari, Florence, Milan, Pavia, Perugia
2025-02-04
Active, closed
AstraZeneca
Phase 2
194
Genoa, Meldola, Milan, Naples, Orbassano, Perugia, Rozzano, Udine
2024-08-27
Recruiting
AstraZeneca
Phase 3
5,250
Ancona, Florence, Genoa, Mestre, Milan, Naples, Pavia, Perugia
2024-02-21
Active, closed
AstraZeneca
Phase 2
194
Candiolo, Milan, Naples, Padova, Perugia, Roma, Siena
2022-08-11
Active, closed
AstraZeneca
Phase 2
367
Avellino, Florence, Milan, Orbassano, Padova, Parma, Perugia, Peschiera del Garda
2019-01-09
Active, closed
AstraZeneca
Phase 3
1,324
Benevento, Meldola, Milan, Naples, Perugia, Pisa, Roma, Rozzano
2017-10-11
Active, closed
AstraZeneca
Phase 3
510
Bari, Genova, Livorno, Milan, Naples, Orbassano, Parma, Perugia
2013-09-25
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/perugia

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies with a site in Perugia that also match the filters currently applied.

How many clinical trials are recruiting in Perugia?

5 of the 10 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Perugia), 10 studies
PhaseStudiesRecruitingShare
Phase 35350%
Phase 24140%
Phase 41110%

Most active sponsors

Lead sponsors with the most studies (Perugia)
Lead sponsorStudiesRecruiting
AstraZeneca105
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.